Hangzhou MatriDx Biotechnology Co., Ltd.
PrivateLast Round
Series C
Extension
Feb 4, 2024
Total Funding Raised
$87.7M
Company Overview
Hangzhou MatriDx Biotechnology Co., Ltd. is a biotechnology company that provides molecular diagnostic solutions for infectious diseases, specializing in metagenomic next-generation sequencing (mNGS) and automated library preparation instruments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou MatriDx Biotechnology Co., Ltd. Comparables
Compare Hangzhou MatriDx Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 金匙医学 | 86% | |
| Vision Medicals | 86% | |
| Micronbrane Medical | 83% |
Hangzhou MatriDx Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Feb 4, 2024 | ||||
| Series C | Oct 8, 2021 | ||||
| Series B | Apr 20, 2020 | ||||
| Series A | May 2, 2018 |
Hangzhou MatriDx Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beijing E-Town International Investment & Development Co., Ltd. | Series B |
| Highlight Capital | Series B, Series A |
| Delta Capital | Series A, Series B |
| Yijing Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2021
$31.14M round led by Yijing Capital
- Apr 20, 2020
$29M round with participation from Highlight Capital and Delta Capital.
Hangzhou MatriDx Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hangzhou MatriDx Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Hangzhou MatriDx Biotechnology Co., Ltd. a public or private company?
Hangzhou MatriDx Biotechnology Co., Ltd. is a private company.
What is the current stock price of Hangzhou MatriDx Biotechnology Co., Ltd.?
Hangzhou MatriDx Biotechnology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Hangzhou MatriDx Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Hangzhou MatriDx Biotechnology Co., Ltd. is not publicly available.
Can I buy Hangzhou MatriDx Biotechnology Co., Ltd. stock?
Hangzhou MatriDx Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Hangzhou MatriDx Biotechnology Co., Ltd.'s last funding round?
Hangzhou MatriDx Biotechnology Co., Ltd.'s most recent funding round was Series C Extension on February 4, 2024.
Who are the main investors in Hangzhou MatriDx Biotechnology Co., Ltd.?
Key investors in Hangzhou MatriDx Biotechnology Co., Ltd. include Highlight Capital, Yijing Capital.
Will Hangzhou MatriDx Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou MatriDx Biotechnology Co., Ltd..
How can I track Hangzhou MatriDx Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Hangzhou MatriDx Biotechnology Co., Ltd.'s secondary market activity and sign up for updates.